Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07227766 · ClinicalTrials.gov registry record · NA

Dietary Reversal of the Reprometabolic Syndrome

A NA study of Infertility, Female and Obesity & Overweight, sponsored by University of Colorado, Denver.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07227766 is a NA study of Infertility, Female and Obesity & Overweight that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 30 participants, below the 381-participant average among 18 other Infertility, Female trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07227766, a NA study of Infertility, Female and Obesity & Overweight, is active but no longer recruiting, sponsored by University of Colorado, Denver.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study proposes to test the specific question that a eucaloric, low-fat diet given to women with obesity will result in an increase in reproductive hormones.

Interventions

  • DIETARY_SUPPLEMENT Low-fat diet

Study Locations (1)

Colorado

  • University of Colorado School of Medicine - Aurora

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-08-10
Est. Completion 2029-12-30
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT07227766

The ClinicalTrials.gov registry entry for NCT07227766 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 381-participant average among 18 other Infertility, Female trials with a reported enrollment target (92% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Infertility, Female appearing as the primary indexed condition, and to 1 intervention - of which Low-fat diet is the first listed.

NCT07227766 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT07227766 about?

NCT07227766 is a clinical study titled "Dietary Reversal of the Reprometabolic Syndrome". This study proposes to test the specific question that a eucaloric, low-fat diet given to women with obesity will result in an increase in reproductive hormones.

What is the current status of trial NCT07227766?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-08-10. Estimated completion is 2029-12-30.

What conditions does trial NCT07227766 study?

This clinical trial studies the following conditions: Infertility, Female, Obesity & Overweight.

What interventions are being tested in trial NCT07227766?

The interventions under investigation include: Low-fat diet (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07227766?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07227766 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility, Female

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.